Company Intelligence

Evolvere BioSciences

Evolvere BioSciences provides enterprise-grade artificial intelligence solutions, delivering specialized Making Next-Generation Antibiotics that Outpace Bacterial Evolution technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.

Headquarters
Oxford, United Kingdom
Founded
2024
Employees
3
Stage
Early
Status
Active
Products
1
Reports
8
Last reviewed
Aug 2026
AI in Healthcare Early Active

Overview

What this company is, what it builds, and who it serves.

Evolvere BioSciences is a Healthcare AI company based in Oxford, United Kingdom, founded in 2024.

Evolvere BioSciences develops making Next-Generation Antibiotics that Outpace Bacterial Evolution.

What it does

Through the deployment of Making Next-Generation Antibiotics that Outpace Bacterial Evolution, Evolvere BioSciences provides computational automation and data intelligence for organizations operating in Artificial Intelligence.

What it builds

Making Next-Generation Antibiotics that Outpace Bacterial Evolution

Why It Matters

Evolvere BioSciences provides enterprise-grade artificial intelligence solutions, delivering specialized Making Next-Generation Antibiotics that Outpace Bacterial Evolution technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.

Products

Products and platforms connected to this company.

Ecosystem

How this company connects across the Brel AI intelligence graph.

Company

Evolvere BioSciences

Industry

Capabilities

  • Making Next-Generation Antibiotics that Outpace Bacterial Evolution

Features

  • Making Next-Generation Antibiotics that Outpace Bacterial Evolution

Country

United Kingdom

Related companies

Official Resources

Official and developer links on file for this company.

Frequently Asked Questions

What does Evolvere BioSciences do?

Evolvere BioSciences specializes in artificial intelligence, developing Making Next-Generation Antibiotics that Outpace Bacterial Evolution to support enterprise software developers and digital transformation teams with scalable, production-grade technology.

Where is Evolvere BioSciences based and when was it founded?

Evolvere BioSciences is based in United Kingdom and was founded in 2024.

What are the main products offered by Evolvere BioSciences?

The flagship platform from Evolvere BioSciences is Making Next-Generation Antibiotics that Outpace Bacterial Evolution, delivered primarily through b2b saas and enterprise api licensing.

Who are the primary target users of Evolvere BioSciences?

Evolvere BioSciences primarily serves enterprise software developers and digital transformation teams seeking reliable artificial intelligence implementations.

Sources & Verification

How this profile is verified and where the information comes from.

Verified
Last reviewed Aug 2026

Request a correction if you represent this company or believe information is inaccurate.